Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 21209394)

1.

A role of sphingosine kinase 1 in head and neck carcinogenesis.

Shirai K, Kaneshiro T, Wada M, Furuya H, Bielawski J, Hannun YA, Obeid LM, Ogretmen B, Kawamori T.

Cancer Prev Res (Phila). 2011 Mar;4(3):454-62. doi: 10.1158/1940-6207.CAPR-10-0299. Epub 2011 Jan 5.

2.

Role for sphingosine kinase 1 in colon carcinogenesis.

Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Uflacker A, Bielawski J, Hannun YA, Obeid LM.

FASEB J. 2009 Feb;23(2):405-14. doi: 10.1096/fj.08-117572. Epub 2008 Sep 29.

3.

The expression of sphingosine kinase-1 in head and neck carcinoma.

Facchinetti MM, Gandini NA, Fermento ME, Sterin-Speziale NB, Ji Y, Patel V, Gutkind JS, Rivadulla MG, Curino AC.

Cells Tissues Organs. 2010;192(5):314-24. doi: 10.1159/000318173. Epub 2010 Jul 2.

4.

Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells.

Albinet V, Bats ML, Huwiler A, Rochaix P, Chevreau C, Ségui B, Levade T, Andrieu-Abadie N.

Oncogene. 2014 Jun 26;33(26):3364-73. doi: 10.1038/onc.2013.303. Epub 2013 Jul 29.

PMID:
23893239
5.

Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.

Gorshkova IA, Wang H, Orbelyan GA, Goya J, Natarajan V, Beiser DG, Vanden Hoek TL, Berdyshev EV.

Life Sci. 2013 Sep 17;93(9-11):359-66. doi: 10.1016/j.lfs.2013.07.017. Epub 2013 Jul 24.

PMID:
23892195
6.

Targeting SphK1 as a new strategy against cancer.

Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S.

Curr Drug Targets. 2008 Aug;9(8):662-73. Review.

7.

Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate.

Kharel Y, Mathews TP, Gellett AM, Tomsig JL, Kennedy PC, Moyer ML, Macdonald TL, Lynch KR.

Biochem J. 2011 Dec 15;440(3):345-53. doi: 10.1042/BJ20110817.

8.

Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer.

Masood R, Roy I, Zu S, Hochstim C, Yong KT, Law WC, Ding H, Sinha UK, Prasad PN.

Integr Biol (Camb). 2012 Feb;4(2):132-41. doi: 10.1039/c1ib00060h. Epub 2011 Dec 7.

PMID:
22159374
9.

Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1.

Tamashiro PM, Furuya H, Shimizu Y, Kawamori T.

Cancer Cell Int. 2014 Aug 29;14(1):76. doi: 10.1186/s12935-014-0076-x. eCollection 2014.

10.

Differential regulation of sphingosine kinases 1 and 2 in lung injury.

Wadgaonkar R, Patel V, Grinkina N, Romano C, Liu J, Zhao Y, Sammani S, Garcia JG, Natarajan V.

Am J Physiol Lung Cell Mol Physiol. 2009 Apr;296(4):L603-13. doi: 10.1152/ajplung.90357.2008. Epub 2009 Jan 23.

11.

K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling.

Ji F, Mao L, Liu Y, Cao X, Xie Y, Wang S, Fei H.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):568-75. doi: 10.1016/j.bbrc.2015.02.007. Epub 2015 Feb 11.

PMID:
25680461
12.

Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.

Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, Milstien S, Zhou H, Spiegel S, Takabe K.

Cancer Res. 2012 Feb 1;72(3):726-35. doi: 10.1158/0008-5472.CAN-11-2167.

13.

Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.

Kohno M, Momoi M, Oo ML, Paik JH, Lee YM, Venkataraman K, Ai Y, Ristimaki AP, Fyrst H, Sano H, Rosenberg D, Saba JD, Proia RL, Hla T.

Mol Cell Biol. 2006 Oct;26(19):7211-23.

14.

The reduction of allograft arteriosclerosis in intestinal transplant is associated with sphingosine kinase 1/sphingosine-1-phosphate signaling after fish oil treatment.

Li Q, Wang C, Zhang Q, Tang C, Li N, Li J.

Transplantation. 2012 May 27;93(10):989-96. doi: 10.1097/TP.0b013e31824d709d.

PMID:
22466786
15.

Loss of sphingosine kinase 1 predisposes to the onset of diabetes via promoting pancreatic β-cell death in diet-induced obese mice.

Qi Y, Chen J, Lay A, Don A, Vadas M, Xia P.

FASEB J. 2013 Oct;27(10):4294-304. doi: 10.1096/fj.13-230052. Epub 2013 Jul 9.

16.

Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin.

Bachmaier K, Guzman E, Kawamura T, Gao X, Malik AB.

PLoS One. 2012;7(2):e30742. doi: 10.1371/journal.pone.0030742. Epub 2012 Feb 15.

17.

The impact of sphingosine kinase-1 in head and neck cancer.

Tamashiro PM, Furuya H, Shimizu Y, Iino K, Kawamori T.

Biomolecules. 2013 Aug 12;3(3):481-513. doi: 10.3390/biom3030481.

18.

Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.

Schnute ME, McReynolds MD, Kasten T, Yates M, Jerome G, Rains JW, Hall T, Chrencik J, Kraus M, Cronin CN, Saabye M, Highkin MK, Broadus R, Ogawa S, Cukyne K, Zawadzke LE, Peterkin V, Iyanar K, Scholten JA, Wendling J, Fujiwara H, Nemirovskiy O, Wittwer AJ, Nagiec MM.

Biochem J. 2012 May 15;444(1):79-88. doi: 10.1042/BJ20111929.

PMID:
22397330
19.

Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.

Tao R, Zhang J, Vessey DA, Honbo N, Karliner JS.

Cardiovasc Res. 2007 Apr 1;74(1):56-63. Epub 2007 Jan 23.

20.

Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation.

Yamanaka M, Shegogue D, Pei H, Bu S, Bielawska A, Bielawski J, Pettus B, Hannun YA, Obeid L, Trojanowska M.

J Biol Chem. 2004 Dec 24;279(52):53994-4001. Epub 2004 Oct 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk